Simulations Plus has announced strategic partnership programmes with three pharmaceutical businesses to advance AI-enabled ...

If Recordati accepts CVC’s offer, the latter company will acquire the remaining 48.2% of the former's public shares.

Analysts say that the approval of J&J's Darzalex in the at-home setting could enhance the drug's accessibility and uptake in ...

Novartis is to acquire biotech business Excellergy, which develops next-generation anti-immunoglobulin e (IgE) therapies, for ...

Corcept's Lifyorli can now be prescribed alongside nab-paclitaxel for patients with ovarian cancer who have relapsed ...

Upon approval, Rocket has been awarded a priority review voucher, which currently fetch around $200m on the secondary market.

GlobalData analysed the product launch and withdrawal trends using its POLI database, comparing activity in the ten months ...

Daiichi Sankyo has collaborated with Tempus AI to expedite the clinical development and differentiation of an ADC programme ...

An expert involved in the first successful gene therapy trial for Huntington's Disease discusses the trial results and ...

At BIO Europe Spring, Pharmaceutical Technology interviewed executives and investors about regional competitiveness and ...

Backed by partner Sanofi, Earendil will expand the utility of its AI-driven drug discovery platform, while progressing its ...

Cognito Therapeutics has partnered with Ochsner Health to establish the Brain Health Collaboratory, aiming to advance new ...